Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Blue Owl Capital Holdings

Latest statistics and disclosures from Blue Owl Capital Holdings's latest quarterly 13F-HR filing:

Top 5 stock holdings are NCDL, OBDC, ENGN, LRMR, EVCM, and represent 39.84% of Blue Owl Capital Holdings's stock portfolio.
Added to shares of these 10 stocks: ROIV (+$15M), RARE (+$5.0M), DELL, Imagenebio, IMRX, LRMR, NU, MREO, HLLY, ACLX.
Started 9 new stock positions in PIPR, Imagenebio, GTLB, KALV, ACLX, ROIV, NU, IMRX, MREO.
Reduced shares in these 10 stocks: TRML (-$16M), NCDL (-$13M), MLYS (-$8.9M), TNGX (-$5.8M), IKNA (-$5.5M), TEM (-$5.1M), CNTA, ENGN, EYPT, .
Sold out of its positions in APGE, BMEA, CABA, IKNA, KPLT, STWD, TEM, TRML, RZLV.
Blue Owl Capital Holdings was a net seller of stock by $-26M.
Blue Owl Capital Holdings has $322M in assets under management (AUM), dropping by 3.96%.
Central Index Key (CIK): 0001858703

Tip: Access up to 7 years of quarterly data

Positions held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Blue Owl Capital Holdings

Blue Owl Capital Holdings holds 72 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Nuveen Churchill Direct Lend Com Shs (NCDL)	13.2	$43M	-23%	3.1M	13.80	View chart
Owl Rock Capital Corporation (OBDC)	8.1	$26M		2.0M	12.77	View chart
Engene Holdings (ENGN)	7.0	$22M	-12%	3.3M	6.83	View chart
Larimar Therapeutics (LRMR)	5.9	$19M	+18%	5.9M	3.23	View chart
Evercommerce (EVCM)	5.7	$18M		1.6M	11.13	View chart
Holley (HLLY)	4.7	$15M	+18%	4.9M	3.14	View chart
Roivant Sciences SHS (ROIV)	4.6	$15M	NEW	988k	15.13	View chart
Cullinan Oncology (CGEM)	4.6	$15M	+5%	2.5M	5.93	View chart
Ultragenyx Pharmaceutical (RARE)	3.9	$13M	+65%	422k	30.08	View chart
Conduent Incorporate (CNDT)	3.9	$13M		4.5M	2.80	View chart
Sagimet Biosciences Com Ser A (SGMT)	2.8	$9.1M		1.3M	6.86	View chart
Compass Therapeutics (CMPX)	2.8	$9.1M		2.6M	3.50	View chart
Dell Technologies CL C (DELL)	2.3	$7.4M	+151%	52k	141.77	View chart
Civeo Corp Cda Com New (CVEO)	2.3	$7.3M		317k	23.00	View chart
Context Therapeutics (CNTX)	2.2	$7.2M		7.4M	0.97	View chart
Aquestive Therapeutics (AQST)	2.2	$7.0M	+35%	1.3M	5.59	View chart
Disc Medicine (IRON)	2.1	$6.8M	-16%	102k	66.08	View chart
Repare Therapeutics Ord (RPTX)	1.9	$6.1M		3.4M	1.76	View chart
Palvella Therapeutics Inc Ne (PVLA)	1.9	$6.0M	-23%	95k	62.69	View chart
Eyepoint Pharmaceuticals Com New (EYPT)	1.6	$5.2M	-34%	368k	14.24	View chart
Korro Bio (KRRO)	1.6	$5.0M	-16%	105k	47.89	View chart
Imagenebio	1.4	$4.4M	NEW	541k	8.15	View chart
Pliant Therapeutics (PLRX)	1.4	$4.4M		3.0M	1.48	View chart
Centessa Pharmaceuticals Sponsored Ads (CNTA)	1.3	$4.1M	-48%	170k	24.25	View chart
Immuneering Corp Class A Com (IMRX)	1.2	$3.9M	NEW	550k	7.00	View chart
Mineralys Therapeutics (MLYS)	1.2	$3.8M	-69%	101k	37.92	View chart
Compass Pathways Sponsored Ads (CMPS)	1.1	$3.5M	+163%	605k	5.73	View chart
Adc Therapeutics Sa SHS (ADCT)	0.9	$2.9M		734k	4.00	View chart
Nu Hldgs Ord Shs Cl A (NU)	0.9	$2.8M	NEW	174k	16.01	View chart
Mereo Biopharma Group Spon Ads (MREO)	0.8	$2.6M	NEW	1.3M	2.06	View chart
Eledon Pharmaceuticals (ELDN)	0.8	$2.5M	-26%	980k	2.59	View chart
Arcellx Common Stock (ACLX)	0.7	$2.2M	NEW	27k	82.10	View chart
Kalvista Pharmaceuticals (KALV)	0.5	$1.5M	NEW	125k	12.18	View chart
Fold Hldgs Com Cl A (FLD)	0.4	$1.4M		857k	1.69	View chart
Niocorp Devs *w Exp 03/17/202 (NIOBW)	0.3	$1.0M		546k	1.84	View chart
Tango Therapeutics (TNGX)	0.3	$1.0M	-85%	119k	8.40	View chart
Enterprise Products Partners (EPD)	0.3	$978k		31k	31.27	View chart
Gitlab Class A Com (GTLB)	0.2	$557k	NEW	12k	45.08	View chart
Shf Holdings Cl A New (SHFS)	0.2	$543k		76k	7.16	View chart
Servicetitan Shs Cl A (TTAN)	0.2	$500k	-56%	5.0k	100.83	View chart
Marker Therapeutics Com New (MRKR)	0.2	$495k		554k	0.89	View chart
Rezolve Ai *w Exp 08/15/202 (RZLVW)	0.1	$470k	-38%	293k	1.60	View chart
Alpha Modus Hldgs Cl A (AMOD)	0.1	$454k		394k	1.15	View chart
Cardinal Health (CAH)	0.1	$270k		1.7k	156.96	View chart
Piper Jaffray Companies (PIPR)	0.1	$211k	NEW	607.00	346.99	View chart
Southland Hldgs *w Exp 02/14/202 (SLND.WS)	0.1	$166k		860k	0.19	View chart
Alpha Modus Hldgs *w Exp 12/13/202 (AMODW)	0.0	$144k		1.9M	0.08	View chart
Blue Gold *w Exp 04/01/203 (BGLWW)	0.0	$80k		175k	0.46	View chart
Syntec Optics Hldgs *w Exp 99/99/999 (OPTXW)	0.0	$70k		803k	0.09	View chart
Blacksky Technology *w Exp 09/09/202 (BKSY.WS)	0.0	$59k		350k	0.17	View chart
Cid Holdco *w Exp 12/31/202 (DAICW)	0.0	$46k		300k	0.15	View chart
Aeon Biopharma Cl A New (AEON)	0.0	$34k		42k	0.81	View chart
Dave *w Exp 01/05/202 (DAVEW)	0.0	$31k		29k	1.08	View chart
Livewire Group *w Exp 09/26/202 (LVWR.WS)	0.0	$29k		400k	0.07	View chart
Engene Holdings *w Exp 10/31/202 (ENGNW)	0.0	$26k		36k	0.71	View chart
Brand Engagement Network *w Exp 03/14/202 (BNAIW)	0.0	$26k		1.7M	0.02	View chart
Pagaya Technologies *w Exp 99/99/999 (PGYWW)	0.0	$24k		49k	0.50	View chart
Roadzen *w Exp 11/30/202 (RDZNW)	0.0	$16k		225k	0.07	View chart
Nvni Group *w Exp 11/01/202 (NVNIW)	0.0	$14k		200k	0.07	View chart
Zeo Energy Corp *w Exp 03/13/202 (ZEOWW)	0.0	$14k		250k	0.06	View chart
Bitcoin Depot *w Exp 06/30/202 (BTMWW)	0.0	$12k		50k	0.25	View chart
Tevogen Bio Hldgs *w Exp 02/14/202 (TVGNW)	0.0	$11k		200k	0.06	View chart
Liminatus Pharma *w Exp 04/30/203 (LIMNW)	0.0	$7.4k		50k	0.15	View chart
Baird Med Invt Hldgs *w Exp 10/01/202 (BDMDW)	0.0	$6.7k		100k	0.07	View chart
Bolt Projs Hldgs *w Exp 08/13/202 (BSLKW)	0.0	$6.7k		167k	0.04	View chart
Cero Therapeutics Hldgs *w Exp 02/13/202 (CEROW)	0.0	$3.0k		225k	0.01	View chart
Katapult Holdings *w Exp 06/09/202 (KPLTW)	0.0	$2.7k		400k	0.01	View chart
Aspire Biopharma Hldgs *w Exp 02/14/203 (ASBPW)	0.0	$1.5k		50k	0.03	View chart
Waldencast *w Exp 07/27/202 (WALDW)	0.0	$1.2k		33k	0.04	View chart
Xbp Global Holdings *w Exp 11/30/202 (XBPEW)	0.0	$993.597800		25k	0.04	View chart
Stardust Pwr *w Exp 06/21/202 (SDSTW)	0.0	$446.648800		17k	0.03	View chart
Verona Pharma Sponsored Ads (VRNA)	0.0	$97.239100		18k	0.01	View chart

Past Filings by Blue Owl Capital Holdings

SEC 13F filings are viewable for Blue Owl Capital Holdings going back to 2021

Blue Owl Capital Holdings 2025 Q3 filed Nov. 12, 2025
Blue Owl Capital Holdings 2025 Q2 filed Aug. 11, 2025
Blue Owl Capital Holdings 2025 Q1 filed May 15, 2025
Blue Owl Capital Holdings 2024 Q4 filed Feb. 14, 2025
Blue Owl Capital Holdings 2024 Q3 filed Nov. 14, 2024
Blue Owl Capital Holdings 2024 Q2 filed Aug. 15, 2024
Blue Owl Capital Holdings 2024 Q1 filed May 15, 2024
Blue Owl Capital Holdings 2023 Q4 filed Feb. 15, 2024
Blue Owl Capital Holdings 2023 Q3 filed Nov. 14, 2023
Blue Owl Capital Holdings 2023 Q2 filed Aug. 11, 2023
Blue Owl Capital Holdings 2023 Q1 filed May 11, 2023
Blue Owl Capital Holdings 2022 Q4 filed Feb. 13, 2023
Blue Owl Capital Holdings 2022 Q3 filed Nov. 14, 2022
Blue Owl Capital Holdings 2022 Q2 filed Aug. 12, 2022
Blue Owl Capital Holdings 2021 Q4 restated filed May 16, 2022
Blue Owl Capital Holdings 2021 Q4 amended filed May 16, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z